← Leaderboards
Maria A Rupnick
Brigham And Women'S Hospital
$1,033,796
Attributed
$1,033,796
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243.7K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$1,033,796 · 3
By mechanism
K02$503,415 · 1
R21$285,629 · 1
K08$244,752 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Stephanie A Shore$11,152,764
- Katherine N Cahill$6,985,885
- Howard L Weiner$38,267,107
- Guo-Ping Shi$19,551,120
- Eric Garland Sheu$3,405,774
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseAdipose TissueAngiopoietinsAngiogenesisVascular Endothelial Growth FactorsAngiogenesis InhibitorsBlood VesselsGenetically Modified AnimalsConnective Tissue NeoplasmCell ProliferationAdipocytesLeptinDrug Design /Synthesis /ProductionHuman TissueChemical StructureDrug Screening /EvaluationChemical StabilityCopolymer IApoptosisClinical ResearchAtrial Natriuretic PeptideDrug Delivery SystemsDrug Administration Rate /DurationGene Expression
Grant awards (9)
Vessel Maturation as a Regulator of Tissue Remodeling$100,683
K02 · FY2007 · HL · contact PI
Vessel Maturation as a Regulator of Tissue Remodeling$100,683
K02 · FY2006 · HL · contact PI
Role of Vessel Maturity in Antiangiogenic Drug Efficacy$143,010
R21 · FY2005 · CA
Vessel Maturation as a Regulator of Tissue Remodeling$100,683
K02 · FY2005 · HL
Role of Vessel Maturity in Antiangiogenic Drug Efficacy$142,619
R21 · FY2004 · CA
Vessel Maturation as a Regulator of Tissue Remodeling$100,683
K02 · FY2004 · HL
Vessel Maturation as a Regulator of Tissue Remodeling$100,683
K02 · FY2003 · HL
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR$122,376
K08 · FY2001 · HL
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR$122,376
K08 · FY2000 · HL